“…A significant example is provided by the contradictory results generated by using the transmembrane protein CD133 as a stem-cell marker. In numerous studies, monoclonal antibodies to CD133 were defined as appropriate tools to isolate CSC from various tumour types (Barker et al, 2009;Yin et al, 1997;Uchida et al, 2000;Lee et al, 2005;Sagrinati et al, 2006;Richardson et al, 2004;Kordes et al, 2007;Oshima et al, 2007;Sugiyama et al, 2007;Ito et al, 2007). Nonetheless, by generating transgenic mice expressing the LacZ reporter gene under the control of the CD133 promoting sequences, the transmembrane protein was found expressed by mature luminal ductal epithelial cells in adult organs, suggesting that it is not a specific marker of stem-cells (Shmelkov et al, 2008).…”